-
21
-
22
Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
Published 2016-02-01Subjects: “…Long-term results – Lucentis – Neovascular AMD…”
Get full text
Article -
23
-
24
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
Published 2007-01-01Subjects: Get full text
Article -
25
Immediate sequential bilateral intravitreal injections: an Indian perspective
Published 2017-04-01Subjects: Get full text
Article -
26
-
27
-
28
-
29
-
30
Effect analysis of the intravitreal Conbercept in the treatment of choroid neovascularization of macular with high myopia
Published 2021-06-01Subjects: Get full text
Article -
31
EXPERIENCE OF SURGICAL TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY
Published 2016-11-01Subjects: Get full text
Article -
32
Application of anti-VEGF agents on the treatment of neovascular glaucoma
Published 2016-01-01Subjects: Get full text
Article -
33
-
34
-
35
Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
Published 2013-04-01Subjects: Get full text
Article -
36
Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
Published 2019-07-01Subjects: Get full text
Article -
37
-
38
-
39
Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity
Published 2019-08-01Subjects: Get full text
Article -
40
Role of ranibizumab in management of macular degeneration
Published 2007-01-01Subjects: Get full text
Article